David Kamp, MD, completed his residency and fellowship at Northwestern, where he now studies a range of lung disorders as well as cellular apoptosis, a process of programmed cell death.
Menu
Browsing: Cancer
A new study has found that large racial/ethnic disparities in colorectal cancer screening persist in America, including substantial differences between English-speaking and Spanish-speaking Hispanics. The research confirmed continued low screening rates among all residents of the U.S.
Recently published research in Human Molecular Genetics shows that removing too much of the enzyme HDAC3 has a toxic effect on the nervous system. The expression of this enzyme is inhibited by drugs being studied as potential treatment options for cancer and neurodegeneration
Scientists identified a new protein that plays a key role in reprogramming cancer cells to migrate and invade other organs. When that protein is removed from cancer cells in mice models of the disease, the ability of the cells to metastasize to the lungs is dramatically decreased.
Findings published by Northwestern Medicine scientists in Molecular Cell suggest that the upregulation of protein WDR5 may be crucial in prostate cancer development.
Kamonwan Pear Fish, a PhD/MPH student, uses mouse models to study how a viral protein from the Epstein Barr Virus can disrupt cell function and accelerate tumor growth.
Shelby Rubin, PA ’15, has already accomplished something most people haven’t – the founding and running of a nonprofit organization called Camp Kesem, a free summer camp for children ages 6 to 16 whose lives have been affected by a parent’s cancer.
Despite advances in neurosurgical techniques and radiation oncology, malignant brain tumors are the fourth most common cancer death in the United States. A recent publication by Northwestern Medicine scientists has revealed a potentially novel treatment option.
Findings indicate that regular vitamin D screenings may be beneficial, especially for African- and European-American men.
Scientists from five institutions, including Northwestern, discovered a cancer-specific biomarker found in all stages of breast, prostate and pancreatic cancers.